3 results match your criteria: "China Jiangsu Province Hospital of Chinese Medicine Nanjing 210029[Affiliation]"
Zhongguo Zhong Yao Za Zhi
March 2022
Affiliated Hospital of Nanjing University of Chinese Medicine Nanjing 210029, China Jiangsu Province Hospital of Chinese Medicine Nanjing 210029, China.
This study was designed to assess the clinical efficacy of oral blood-activating and stasis-removing Chinese patent medicines in treating hypertensive left ventricular hypertrophy(LVH) based on network Meta-analysis. The clinical randomized controlled trials(RCTs) concerning the treatment of hypertensive LVH with oral blood-activating and stasis-removing Chinese patent medicines were retrieved from CNKI, Wanfang, VIP, SinoMed, PubMed, Web of Science, and Cochrane Library from their inception to September 2021. Two researchers independently completed the literature screening, data extraction, and quality evaluation.
View Article and Find Full Text PDFZhongguo Zhong Yao Za Zhi
March 2022
Affiliated Hospital of Nanjing University of Chinese Medicine Nanjing 210029, China Nanjing University of Chinese Medicine Nanjing 210023, China Jiangsu Province Hospital of Chinese Medicine Nanjing 210029, China.
UPLC-Q-TOF-MS combined with network pharmacology and experimental verification was used to explore the mechanism of acupoint sticking therapy(AST) in the intervention of bronchial asthma(BA). The chemical components of Sinapis Semen, Cory-dalis Rhizoma, Kansui Radix, Asari Radix et Rhizoma, and Zingiberis Rhizoma Recens were retrieved from TCMSP as self-built database. The active components in AST drugs were analyzed by UPLC-Q-TOF-MS, and the targets were screened out in TCMSP and Swiss-TargetPrediction.
View Article and Find Full Text PDFZhongguo Zhong Yao Za Zhi
October 2020
Affiliated Hospital of Nanjing University of Chinese Medicine Nanjing 210029, China Jiangsu Province Hospital of Chinese Medicine Nanjing 210029, China Nanjing University of Chinese Medicine Nanjing 210023, China.
To assess the clinical efficacy of Huoxue Huayu Chinese medicine injections on hypertensive nephropathy by using Network Meta-analysis method. The relative randomized controlled trials(RCTs) of Huoxue Huayu Chinese medicine injections on hypertensive nephropathy were retrieved from CNKI, WanFang, VIP, SinoMed, PubMed, Cochrane Library and Web of Science in November 2019. Two researchers independently conducted literature screening, data extraction and quality evaluation.
View Article and Find Full Text PDF